AI-Designed Pan-Coronavirus Vaccine Completes First Human Test, Initial Safety Clears Bar
This early trial pushes the vaccine strategy from “chasing variants with updates” toward a defense aimed at an entire virus family; immune responses have been observed, but true protection still awaits answers from larger studies.